Having developed more than 100 economic models over the past decade, Xcenda is broadly recognized as a leader in both the development of economic models and new modeling methodologies. Are you considering partnering with us? Here are a few quick reasons why we think you should:
Xcenda provides the following types of economic models:
Leverage your product’s value story with the development of a cost-effectiveness model in Excel or TreeAge. Cost-effectiveness models compare the value of pharmaceuticals, medical devices, procedures, or diagnostics by quantifying the cost per unit of effectiveness. More expensive and more effective products can be shown to provide good value for the money. Xcenda’s modeling team can design and develop a model to support your product’s unique value story. We have experience developing everything from simple decision tree models to complex Markov models. We can also assist you in developing a strategy to communicate your product’s value story through presentations and publication of abstracts, posters, and manuscripts.
If you have a new drug coming to market (or a new indication), then you need an AMCP dossier and a budget impact model. Budget impact models quantify the cost of a new drug to managed care payers. Xcenda’s modeling team can help you design a budget impact model that captures all the economic benefits of your product, including reduced administration costs, medical cost offsets, and reductions in adverse event rates. We can meet your timeline requirements for Excel budget impact models for use in your dossier, complete with enhanced graphics, navigation, and macros to provide payers a credible and user-friendly model.
If you are first to market in a disease state that payers know little about, then you need a disease burden model to quantify the clinical and economic burden of the disease. Xcenda’s modeling team can help you put a disease on the radar screen of payers by showing them the full economic costs associated with the disease. These costs represent the potential economic benefits due to the introduction of improved therapies to treat the disease. We can help you publish the results from a disease burden model to communicate the existing clinical and economic burden of the disease and the potential benefits of therapy through the publication of abstracts, posters, and manuscripts.
Unveiling the Mysteries of Pharmacoeconomic Models: A Look at the Methods, Data Sources, and Applications.
"I am very pleased with the fantastic job Xcenda's health outcomes team has done in conceptualizing and executing the development of the model with technical rigor. Your team explored many of our key opinion leader's ideas and directions while still completing the model on-time. Keep up the good work, guys. I'll look forward to continued partnership with Xcenda."
Senior Director, Global Health Economics, medical device firm